Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.5201
+0.0274 (5.56%)
At close: Sep 2, 2025, 4:00 PM
0.5305
+0.0104 (2.00%)
After-hours: Sep 2, 2025, 7:55 PM EDT
Applied Therapeutics Employees
Applied Therapeutics had 35 employees as of December 31, 2024. The number of employees increased by 10 or 40.00% compared to the previous year.
Employees
35
Change (1Y)
10
Growth (1Y)
40.00%
Revenue / Employee
$3,457
Profits / Employee
-$1,935,400
Market Cap
74.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35 | 10 | 40.00% |
| Dec 31, 2023 | 25 | -2 | -7.41% |
| Dec 31, 2022 | 27 | -7 | -20.59% |
| Dec 31, 2021 | 34 | 10 | 41.67% |
| Dec 31, 2020 | 24 | 13 | 118.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
APLT News
- 20 days ago - Applied Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Applied Therapeutics Announces Key Leadership Appointments - GlobeNewsWire
- 3 months ago - Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewsWire
- 4 months ago - Applied Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewsWire
- 5 months ago - Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission - GlobeNewsWire
- 5 months ago - Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - GlobeNewsWire
- 7 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Accesswire